Hariharan Selena, Mezoff Ethan A, Dandoy Christopher E, Zhang Yue, Chiarenzelli Janis, Troutt Misty L, Simpkins Jean, Dewald Mary, Klotz Kim, Mezoff Adam G, Cole Conrad R
Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
Pediatr Qual Saf. 2018 Jul 20;3(4):e090. doi: 10.1097/pq9.0000000000000090. eCollection 2018 Jul-Aug.
Pediatric intestinal failure (IF) patients experience significant morbidity, including sepsis related to central line-associated bloodstream infections. Adult studies of sepsis demonstrate an association between time to antibiotic administration (TTA) and mortality. To overcome challenges in treating pediatric IF patients in an emergency department (ED), we appropriated an existing, reliable system for febrile immunocompromised oncology/bone marrow transplant children. We describe the translation of this process to febrile IF patients in the ED and steps toward sustained improvement.
We formed a multidisciplinary team and used the Model for Improvement to define aims and identify key drivers. The goal was to use an existing improvement process to increase the percentage of patients with IF who receive antibiotics within 60 minutes of arrival to the ED from 46% to 90%. Key drivers included pre- and postarrival processes, staff and family engagement, and a preoccupation with failure. We performed Plan-Do-Study-Act cycles targeting family engagement, prearrival efficiency, and postarrival consistency.
Two hundred seventy-six encounters involving febrile IF patients between November 2012 and March 2017 were evaluated. There was a sustained reduction in the median time from arrival to antibiotic administration (71-45 minutes). We decreased TTA to less than 60 minutes for 77% of febrile IF patients.
The basic tenets of process improvement for 1 high-risk population can be translated to another high-risk population but must be adjusted for variability in characteristics.
儿科肠衰竭(IF)患者面临严重的发病风险,包括与中心静脉导管相关血流感染有关的败血症。成人败血症研究表明抗生素给药时间(TTA)与死亡率之间存在关联。为了克服急诊科(ED)治疗儿科IF患者时遇到的挑战,我们采用了一种现有的、可靠的针对发热免疫功能低下的肿瘤学/骨髓移植儿童的系统。我们描述了将此流程应用于急诊科发热IF患者的过程以及持续改进的步骤。
我们组建了一个多学科团队,并使用改进模型来确定目标和识别关键驱动因素。目标是利用现有的改进流程,将到达急诊科后60分钟内接受抗生素治疗的IF患者比例从46%提高到90%。关键驱动因素包括到达前和到达后的流程、工作人员和家属的参与以及对失败的关注。我们针对家属参与、到达前效率和到达后一致性进行了计划-执行-研究-改进循环。
对2012年11月至2017年3月期间涉及发热IF患者的276次就诊进行了评估。从到达至抗生素给药的中位时间持续缩短(从71分钟降至45分钟)。我们使77%的发热IF患者的TTA缩短至60分钟以内。
针对1个高危人群的流程改进基本原则可应用于另一个高危人群,但必须根据特征差异进行调整。